COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    delta-8
Previous Study | Return to List | Next Study

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00285051
Recruitment Status : Suspended (Study drug expiry date not extended)
First Posted : February 1, 2006
Last Update Posted : April 28, 2017
Teva Branded Pharmaceutical Products R&D, Inc.
Information provided by:
Rafa Laboratories

No Study Results Posted on for this Study
Recruitment Status : Suspended
Primary Completion Date : No date given
Study Completion Date : November 2005